Burden of tuberculosis and its association with socio-economic development status in 204 countries and territories, 1990–2019

Yi, Xue; Zhou, Jie; Wang, Peng; Lan, Junhong; Lian, Wenqin; Fan, Yueying; Xu, Bei-Ni; Yin, Jianhua; Feng, Zihao; Zhou, Jian; Jia, Chiyu

doi:10.3389/fmed.2022.905245

Cited by 10 publications

(7 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nevertheless, tuberculosis was still within the top ten prevalent diseases in 2019; Peru has the second highest tuberculosis burden in the Americas and increasing cases of multi-drug-resistant tuberculosis (MDR-TB) ( 62 , 63 ). Of all the tuberculosis patients in the world, 4.6% have MDR-TB, and this proportion has increased since 1990 ( 64 ). Few studies have explored possible causes for the high rates of MDR-TB.…”

Section: Discussionmentioning

confidence: 99%

Estimating mortality and disability in Peru before the COVID-19 pandemic: a systematic analysis from the Global Burden of the Disease Study 2019

Rios-Blancas,

Pando-Robles,

Razo

et al. 2023

Front. Public Health

View full text Add to dashboard Cite

BackgroundEstimating and analyzing trends and patterns of health loss are essential to promote efficient resource allocation and improve Peru’s healthcare system performance.MethodsUsing estimates from the Global Burden of Disease (GBD), Injuries, and Risk Factors Study (2019), we assessed mortality and disability in Peru from 1990 to 2019. We report demographic and epidemiologic trends in terms of population, life expectancy at birth (LE), mortality, incidence, prevalence, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) caused by the major diseases and risk factors in Peru. Finally, we compared Peru with 16 countries in the Latin American (LA) region.ResultsThe Peruvian population reached 33.9 million inhabitants (49.9% women) in 2019. From 1990 to 2019, LE at birth increased from 69.2 (95% uncertainty interval 67.8–70.3) to 80.3 (77.2–83.2) years. This increase was driven by the decline in under-5 mortality (−80.7%) and mortality from infectious diseases in older age groups (+60 years old). The number of DALYs in 1990 was 9.2 million (8.5–10.1) and reached 7.5 million (6.1–9.0) in 2019. The proportion of DALYs due to non-communicable diseases (NCDs) increased from 38.2% in 1990 to 67.9% in 2019. The all-ages and age-standardized DALYs rates and YLLs rates decreased, but YLDs rates remained constant. In 2019, the leading causes of DALYs were neonatal disorders, lower respiratory infections (LRIs), ischemic heart disease, road injuries, and low back pain. The leading risk factors associated with DALYs in 2019 were undernutrition, high body mass index, high fasting plasma glucose, and air pollution. Before the COVID-19 pandemic, Peru experienced one of the highest LRIs-DALYs rates in the LA region.ConclusionIn the last three decades, Peru experienced significant improvements in LE and child survival and an increase in the burden of NCDs and associated disability. The Peruvian healthcare system must be redesigned to respond to this epidemiological transition. The new design should aim to reduce premature deaths and maintain healthy longevity, focusing on effective coverage and treatment of NCDs and reducing and managing the related disability.

show abstract

Section: Discussionmentioning

confidence: 99%

Estimating mortality and disability in Peru before the COVID-19 pandemic: a systematic analysis from the Global Burden of the Disease Study 2019

Rios-Blancas,

Pando-Robles,

Razo

et al. 2023

Front. Public Health

View full text Add to dashboard Cite

show abstract

“…The ASMR and ASDR of NASH-related liver cancer due to HFPG showed an inverted U-shaped relationship with SDI levels, with middle SDI countries having the heaviest burden. In general, a higher SDI is related to better health literacy, sufficient medical resources, and the implementation of preventive measures, which might usually result in a lower disease burden [ 21 , 41 , 42 ]. However, the relationship between SDI and disease burden differs among different diseases.…”

Section: Discussionmentioning

confidence: 99%

Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990–2019: analysis of data from the 2019 Global Burden of Disease Study

Yang

et al. 2023

Diabetol Metab Syndr

View full text Add to dashboard Cite

Background Experimental and epidemiological studies have indicated an association between diabetes exposure and an increased risk of liver cancer due to nonalcoholic steatohepatitis (NASH). However, to date, no systematic study has specifically investigated the burden of NASH-related liver cancer due to exposure to high fasting plasma glucose (HFPG) levels worldwide. Methods The number and rate of deaths and disability-adjusted life years (DALYs) from HFPG-induced NASH-related liver cancer were estimated based on the results of the 2019 Global Burden of Disease Study. The estimated annual percentage changes (EAPCs) for age-standardized death or DALYs rates were calculated using a generalized linear model with a Gaussian distribution to quantify the temporal trends in the global burden of NASH-related liver cancer attributable to HFPG. The strength and direction of the association between the sociodemographic index (SDI) and death or DALY rate were measured using Spearman’s rank-order correlation. Results Globally, approximately 7.59% of all DALY and 8.76% of all mortalities of NASH-related liver cancer in 2019 were due to HFPG. The age-standardized death and DALY rates of NASH-related liver cancer attributable to HFPG increased from 1990 to 2019. The corresponding EAPCs were 0.69 (95% UI 0.48–0.89), and 0.30 (95% UI 0.05–0.56), respectively. This increasing pattern was most obvious in the high- and low-SDI regions. The age-standardized mortality and DALYs rate of NASH-related liver cancer attributable to HFPG varies considerably worldwide, with the middle SDI region having the highest death and DALY rates in 2019 (DALY 0.96 [95% UI 0.23–2.18]; death 0.05 [95% UI 0.01–0.11]). Conclusion The burden of NASH-related liver cancer attributable to HFPG has increased over the past three decades, particularly in regions with high and low SDI.

show abstract

“…Burden measures were normalized based on population and reported per 100,000 to remove the effect of age structure. According to the official guide and the previously selected parameters [ 9 , 29 , 30 ], we chose the number and rate of five RI metrics, including deaths, DALYs, incidence, YLLs, and YLDs. Premature mortality is measured by YLLs, which uses death frequency and age at death to estimate the years of potential life lost [ 29 , 31 ].…”

Section: Methodsmentioning

confidence: 99%

“…In this study, we assumed all the data including incidence, deaths, DALYs, YLDs, and YLLs were log-normally distributed. We applied the same method used in other papers in the GBD study design to calculate significance [ 30 ]. This study presents the 95% confidence intervals (CIs) calculated using 2.5th and 97.5th percentiles.…”

Section: Methodsmentioning

confidence: 99%

Global, Regional, and National Burden of Road Injuries from 1990 to 2019

Chen

Yang

et al. 2022

IJERPH

View full text Add to dashboard Cite

(1) Background: Understanding occurrence can help formulate effective preventative laws and regulations. However, the most recent global burden and road injuries (RIs) trends have not been reported. This study reports the burden of RIs globally from 1990 to 2019. (2) Methods: RIs data were downloaded from the Global Burden of Disease 2019. Incidence, deaths, and disability-adjusted life years (DALYs) described the trend and burden of RIs. We calculated age-standardized rates (ASRs) and estimated annual percentage change (EAPC) for the above indexes to evaluate the temporal trend of RIs. We evaluated the social-demographic index (SDI) with epidemiological RI parameters and reported proportions of age-standardized rates due to RI. (3) Results: In 2019, the global incidence of RIs reached 103.2 million. The EAPC of RI incidence increased, whereas deaths and DALYs decreased. Age-standardized incident rate (ASIR) was highest in low-middle SDI regions, age-standardized death rate (ASDR) was high in middle SDI regions, and age-standardized DALYs increased in low SDI regions. The highest accident rates were found in those aged 20–24 years old. Cyclist injuries were the leading RIs (34%), though pedestrian and motor vehicle accidents were the leading cause of death (37.4%, 37.6%) and DALYs (35.7%, 32.3%), respectively. (4) Conclusions: Over the past 30 years, RIs incidence increased annually, though death and DALY rates decreased. RIs places a considerable burden on public health in low SDI countries. Data should be used to develop and implement effective measures to reduce the burden of RIs.

show abstract

Burden of tuberculosis and its association with socio-economic development status in 204 countries and territories, 1990–2019

Cited by 10 publications

References 31 publications

Estimating mortality and disability in Peru before the COVID-19 pandemic: a systematic analysis from the Global Burden of the Disease Study 2019

Estimating mortality and disability in Peru before the COVID-19 pandemic: a systematic analysis from the Global Burden of the Disease Study 2019

Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990–2019: analysis of data from the 2019 Global Burden of Disease Study

Global, Regional, and National Burden of Road Injuries from 1990 to 2019

Contact Info

Product

Resources

About